Home/Investors/UTokyo Innovation Platform Co., Ltd.

UTokyo Innovation Platform Co., Ltd.

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

4

Top Stage

preclinical

Investment Focus

Oncology Infectious Disease Regenerative Medicine Genetic Disorders

Portfolio Companies

Company	Stage	Valuation	Focus
AccuRna	preclinical	—	Oncology, Infectious Disease
aceRNA Technology	preclinical	—	Regenerative Medicine, Genetic Disorders
FIMECS	preclinical	—	Oncology

Frequent Co-Investors

Kyoto University Innovation Capital Co., Ltd.2 shared Fast Track Initiative, Inc.1 shared SMBC Venture Capital Co., Ltd.1 shared NanoCarrier Co., Ltd.1 shared Mitsubishi UFJ Capital Co., Ltd.1 shared Takeda Pharmaceutical Co., Ltd.1 shared Cosmo Bio Co., Ltd.1 shared ANRI Co., Ltd.1 shared